Proxy Votes Now

Home › Asset managers › Capital Group › 2025-2026 › Against the board

Capital Group 2025-2026: where it broke with the board

835 proposals in the 2025-2026 proxy season: Capital Group voted against, or withheld its votes from, 829 proposals put forward by company boards, and voted for 6 shareholder proposals, by its own Form N-PX filings.

Two kinds of vote are listed: a board-sponsored proposal Capital Group voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

The list includes the pay votes in Capital Group’s institutional-manager report, which by rule covers only executive pay.

Everything Only shareholder proposals it backed

835 proposals.

Capital Group, 2025-2026 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedCapital Group votedFunds
CONMED Corporation May 18, 2026 Advisory vote to approve named executive officer compensation. Say-on-Pay Board AGAINST 2
Camping World Holdings, Inc. May 21, 2026 Approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Century Communities, Inc. May 6, 2026 To approve, on an advisory basis, our executive compensation. Say-on-Pay Board (inferred) AGAINST 2
Coats Group Plc May 20, 2026 Authorise Issue of Equity without Pre-emptive Rights Capital Structure Board AGAINST 2
Coats Group Plc May 20, 2026 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment Capital Structure Board AGAINST 2
DPC Dash Ltd. May 28, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Denali Therapeutics Inc. June 3, 2026 Advisory vote on executive compensation. Say-on-Pay Board AGAINST 2
Deutsche Lufthansa AG May 12, 2026 Approve Remuneration Report Compensation Board AGAINST 2
Digital Realty Trust, Inc. May 29, 2026 Election of Directors: Mary Hogan Preusse Director Elections Board AGAINST 2
Dr. Lal PathLabs Limited December 7, 2025 Approve Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 Compensation Board AGAINST 2
Dr. Lal PathLabs Limited December 7, 2025 Approve Grant Options to the Employees of the Subsidiary Company(ies) under Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 Compensation Board AGAINST 2
Dr. Lal PathLabs Limited December 7, 2025 Approve Provision of Money to be Provided by the Company for Purchase of Its Own Share by the Trust under Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 Compensation Board AGAINST 2
Dr. Lal PathLabs Limited December 7, 2025 Approve Secondary Acquisition of Shares through Trust Route for the Implementation of Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 Compensation Board AGAINST 2
Duolingo, Inc. June 3, 2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Elastic N.V. September 30, 2025 Non-binding advisory vote to approve the compensation of the Company's named executive officers as described in the proxy statement Say-on-Pay Board AGAINST 2
Emaar Development PJSC March 26, 2026 Elect Ahmed Jawah as Director Director Elections Board ABSTAIN 2
Emaar Development PJSC March 26, 2026 Elect Ali Al Mutawaa as Director Director Elections Board ABSTAIN 2
Emaar Development PJSC March 26, 2026 Elect Zaynab Al Baloushi as Director Director Elections Board ABSTAIN 2
FIT Hon Teng Limited May 26, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
FIT Hon Teng Limited May 26, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Fast Retailing Co., Ltd. November 27, 2025 Elect Director Shintaku, Masaaki Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Alberto Marone as Director Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Francesco Signoretti as Director Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Gabriella Scapicchio as Director Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Giuseppe Pisani as Director Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Maria Giovanna Calloni as Director Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Micaela Cristina Capelli as Director Director Elections Board AGAINST 2
FinecoBank SpA April 29, 2026 Elect Stefano Blotto as Director Director Elections Board AGAINST 2
FirstCash Holdings, Inc. June 9, 2026 Approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions Board AGAINST 2
GEK Terna SA June 16, 2026 Authorize Share Capital Increase and/or Issuance of Convertible Bonds without Preemptive Rights Capital Structure Board AGAINST 2
GitLab Inc. June 17, 2026 Approve, on a non-binding advisory basis, the compensation paid by GitLab Inc. to its named executive officers. Say-on-Pay Board (inferred) AGAINST 2
Goodman Group November 11, 2025 Approve the Spill Resolution Compensation Board AGAINST 2
Goosehead Insurance, Inc. May 4, 2026 Non-binding and advisory resolution approving the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 2
Haitian International Holdings Limited May 22, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Haitian International Holdings Limited May 22, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Halyk Bank of Kazakhstan JSC April 23, 2026 Elect Zhomart Nurabayev as Director Director Elections Board AGAINST 2
Harbin Electric Company Limited May 22, 2026 Approve General Mandate to Issue H Shares Capital Structure Board AGAINST 2
Henderson Land Development Company Limited June 2, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Henderson Land Development Company Limited June 2, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Hill & Smith Plc May 21, 2026 Authorise Issue of Equity without Pre-emptive Rights Capital Structure Board AGAINST 2
Hill & Smith Plc May 21, 2026 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment Capital Structure Board AGAINST 2
Hiscox Ltd. May 14, 2026 Authorise Issue of Equity without Pre-emptive Rights Capital Structure Board AGAINST 2
Hiscox Ltd. May 14, 2026 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment Capital Structure Board AGAINST 2
Humana Inc. April 16, 2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. Say-on-Pay Board AGAINST 2
IDEAYA Biosciences, Inc. June 16, 2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and Say-on-Pay Board AGAINST 2
Impro Precision Industries Limited May 26, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Impro Precision Industries Limited May 26, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Inox Wind Limited June 22, 2026 Approve Continuation of Directorship of Mukesh Manglik as Non-Executive Director Director Elections Board AGAINST 2
Intapp, Inc. November 18, 2025 To conduct an advisory vote to approve named executive officer compensation ("Say-On-Pay Vote"). Say-on-Pay Board (inferred) AGAINST 2
International Workplace Group Plc May 19, 2026 Authorise Issue of Equity without Pre-emptive Rights Capital Structure Board AGAINST 2
International Workplace Group Plc May 19, 2026 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment Capital Structure Board AGAINST 2
Israel Discount Bank Ltd. September 15, 2025 Elect Esti Peshin as Director Director Elections Board ABSTAIN 2
Israel Discount Bank Ltd. September 15, 2025 Elect Gur Nabel as External Director Director Elections Board ABSTAIN 2
Israel Discount Bank Ltd. June 17, 2026 Elect Amalia Avramov as Director Director Elections Board AGAINST 2
Israel Discount Bank Ltd. June 17, 2026 Elect Ohad Marani as External Director Director Elections Board AGAINST 2
Israel Discount Bank Ltd. June 17, 2026 Elect Yaniv Garty as Director Director Elections Board AGAINST 2
JD Health International Inc. June 29, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
JD Health International Inc. June 29, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Janus Henderson Group Plc May 29, 2026 Advisory Say-on-Pay Vote on Executive Compensation. Say-on-Pay Board (inferred) AGAINST 2
KGHM Polska Miedz SA June 9, 2026 Elect Supervisory Board Member Director Elections Board ABSTAIN 2
Kadokawa Corp. June 24, 2026 Elect Director Natsuno, Takeshi Director Elections Board AGAINST 2
KalVista Pharmaceuticals, Inc. October 1, 2025 Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 2
Kymera Therapeutics, Inc. June 24, 2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and Say-on-Pay Board AGAINST 2
Lamb Weston Holdings, Inc. September 25, 2025 Election of Directors: Andre J. Hawaux Director Elections Board AGAINST 2
Lamb Weston Holdings, Inc. September 25, 2025 Election of Directors: Hala G. Moddelmog Director Elections Board AGAINST 2
Lamb Weston Holdings, Inc. September 25, 2025 Election of Directors: Peter J. Bensen Director Elections Board AGAINST 2
Lamb Weston Holdings, Inc. September 25, 2025 Election of Directors: Robert J. Coviello Director Elections Board AGAINST 2
Lennar Corporation April 8, 2026 Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Amy Banse Director Elections Board AGAINST 2
Lennar Corporation April 8, 2026 Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Sherrill W. Hudson Director Elections Board AGAINST 2
Lennar Corporation April 8, 2026 Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Stuart Miller Director Elections Board AGAINST 2
Lennar Corporation April 8, 2026 Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Teri P. McClure Director Elections Board AGAINST 2
MARA Holdings, Inc. June 18, 2026 Approval of an amendment to our Amended and Restated 2018 Equity Incentive Plan (the "2018 Plan") to increase the number of shares of our common stock reserved under the 2018 Plan by 18 million shares. Compensation Board AGAINST 2
MARUWA CO., LTD. June 19, 2026 Approve Allocation of Income, with a Final Dividend of JPY 51 Capital Structure Board AGAINST 2
MARUWA CO., LTD. June 19, 2026 Elect Director Kambe, Toshiro Director Elections Board AGAINST 2
Magnite, Inc. June 8, 2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Marqeta, Inc. June 10, 2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 2
Mayr-Melnhof Karton AG April 29, 2026 Approve Remuneration Policy Compensation Board AGAINST 2
Mayr-Melnhof Karton AG April 29, 2026 Approve Remuneration Report Compensation Board AGAINST 2
Minth Group Limited June 30, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Mirum Pharmaceuticals, Inc. June 15, 2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay Board (inferred) AGAINST 2
Moelis & Company June 25, 2026 To approve, on an advisory basis, the compensation of our Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 2
NMI Holdings, Inc. May 14, 2026 Advisory approval of NMI Holdings, Inc.'s executive compensation. Say-on-Pay Board (inferred) AGAINST 2
Nanobiotix SA June 9, 2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Industrial Companies, Institutions or Entities Active in the Health or Biotechnology Sector, up to Aggregate Nominal Amount of EUR 1,452,302.54 Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Qualified Investors Active in the Health or Biotechnology Sector and Financial Institutions, up to Aggregate Nominal Amount of EUR 1,452,302.54 Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line, up to Aggregate Nominal Amount of EUR 1,452,302.54 Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Approve Issuance of Equity or Equity-Linked Securities for One or More Specifically Designated Persons up to 30 Percent of Issued Share Capital Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Approve Issuance of Equity or Equity-Linked Securities for Private Placements up to Aggregate Nominal Amount of EUR 1,452,302.54 Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 19-21, 23 and 25-26 Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Authorize Capital Increase of Up to EUR 1,452,302.54 for Future Exchange Offers Capital Structure Board AGAINST 2
Nanobiotix SA June 9, 2026 Authorize Capital Issuances for Use in Employee Stock Purchase Plans Compensation Board AGAINST 2
Nanobiotix SA June 9, 2026 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 1,452,302.54 Capital Structure Board AGAINST 2
Nippon Television Holdings, Inc. June 26, 2026 Elect Director Sugiyama, Yoshikuni Director Elections Board AGAINST 2
Nitori Holdings Co., Ltd. June 25, 2026 Elect Director Nitori, Akio Director Elections Board AGAINST 2
Nitori Holdings Co., Ltd. June 25, 2026 Elect Director Shirai, Toshiyuki Director Elections Board AGAINST 2
Nurix Therapeutics, Inc. May 15, 2026 To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 2
OdontoPrev SA April 6, 2026 Approve Independent Firm's Appraisals Extraordinary Transactions Board AGAINST 2
OdontoPrev SA April 6, 2026 Approve Merger Agreement between the Company and Bradesco Gestao de Saude S.A. (BGS) Extraordinary Transactions Board AGAINST 2
OdontoPrev SA April 6, 2026 Approve the Transfer of the Company's Dental Plan Portfolio and Other Operational Assets and Liabilities to Mediservice Operadora de Planos de Saude S.A., Which, as of This Date, Is an Indirect Subsidiary of BGS Extraordinary Transactions Board AGAINST 2
OdontoPrev SA April 6, 2026 Ratify Apsis Consultoria e Avaliacoes Ltda. as Independent Firm to Appraise Proposed Transaction Extraordinary Transactions Board AGAINST 2
PFISTERER Holding SE June 11, 2026 Approve Creation of EUR 9 Million Pool of Authorized Capital with or without Exclusion of Preemptive Rights Capital Structure Board AGAINST 2

← Previous Page 5 of 9 Next →

← Back to Capital Group 2025-2026 overview

Built November 19, 2026 from SEC Form N-PX filings.